Pages that link to "Q57031724"
Jump to navigation
Jump to search
The following pages link to Massimo Federico (Q57031724):
Displaying 50 items.
- ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi (Q28273184) (← links)
- Activin, inhibin and the human breast (Q28284993) (← links)
- Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients. (Q30966717) (← links)
- Prognosis of screen-detected breast cancers: results of a population based study (Q33232320) (← links)
- Cancer incidence in eastern Libya: the first report from the Benghazi Cancer Registry, 2003. (Q33261614) (← links)
- Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. (Q33311606) (← links)
- Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policy. (Q33345685) (← links)
- Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL). (Q33391919) (← links)
- Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project (Q33393849) (← links)
- Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era (Q33558130) (← links)
- Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin (Q33920125) (← links)
- Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. (Q34184665) (← links)
- Classic Kaposi's sarcoma in Italy, 1985-1998 (Q34552954) (← links)
- Pattern of cancer risk in persons with AIDS in Italy in the HAART era. (Q34604639) (← links)
- Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (Q34664223) (← links)
- Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. (Q34675007) (← links)
- Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Ital (Q35195231) (← links)
- The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study. (Q35236063) (← links)
- FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor (Q35999309) (← links)
- Fertility in female survivors of Hodgkin's lymphoma. (Q36283790) (← links)
- Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study. (Q36441553) (← links)
- Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results (Q36716114) (← links)
- Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. (Q37126978) (← links)
- Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients (Q37203919) (← links)
- Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study. (Q37216325) (← links)
- Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility. (Q37306835) (← links)
- What has happened to VBM (vinblastine, bleomycin, and methotrexate) chemotherapy for early-stage Hodgkin lymphoma? (Q37877039) (← links)
- Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. (Q37966305) (← links)
- Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies. (Q38122437) (← links)
- Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature (Q38150543) (← links)
- The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma (Q38190105) (← links)
- Therapeutic options in relapsed or refractory peripheral T-cell lymphoma (Q38246983) (← links)
- Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study. (Q38417399) (← links)
- Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries. (Q38426380) (← links)
- Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper (Q38551290) (← links)
- The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project (Q38602677) (← links)
- Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies (Q38794103) (← links)
- Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study (Q38852024) (← links)
- Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer Registry (Q38985250) (← links)
- A case of skeletal and bone marrow metastases from breast cancer treated with eribulin mesylate. (Q39336799) (← links)
- Acceptability and adherence in a chemoprevention trial among women at increased risk for breast cancer attending the Modena Familial Breast and Ovarian Cancer Center (Italy). (Q39500972) (← links)
- The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines. (Q39986126) (← links)
- Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. (Q40152757) (← links)
- Case studies of elderly patients with non-Hodgkin's lymphoma. (Q40757884) (← links)
- Changes in cervical cancer incidence following the introduction of organized screening in Italy. (Q41146852) (← links)
- Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi. (Q41148150) (← links)
- Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study (Q41407104) (← links)
- KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence (Q41552450) (← links)
- Precision medicine in diffuse large B-cell lymphoma: hitting the target. (Q42399865) (← links)
- Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (Q42427611) (← links)